Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLK-321 in Demodex blepharitis
NCT07400965Phase 2Recruiting
- Sponsor
- Glaukos Corporation
- Start
- Dec 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivermectin in Demodex blepharitis (DB), sponsored by Glaukos Corporation. Started Dec 2025; status: recruiting.
02
Drugs
ivermectin
03
Conditions
Demodex blepharitis (DB)
Beyond the preview
Go deeper on NCT07400965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07400965.